Mode of action of modified and unmodified bacteriocins from Gram-positive bacteria

Biochimie

Volumn 84, Issue 5-6, 2002, Pages 545-557

  Héchard, Yann ^a   Sahl, Hans Georg ^b  

^a UNIVERSITÉ DE POITIERS   (France)

^b UNIVERSITY OF BONN   (Germany)

Author keywords

Antibacterial; Bacteriocin; Lantibiotic; Pore

Indexed keywords

ACTAGARDIN; BACTERIOCIN; BAVARICIN MN; DIVERCIN V41; DURAMYCIN; ENTEROCIN P; EPIDERMIN; LACTACIN F; LACTOCOCCIN G; LANTHIOPEPTIN; LANTIBIOTIC; LEUCOCIN A; LIPID; MANNOSE PERMEASE; MERSACIDIN; MESENTERICIN Y105; NISIN; PEDIOCIN JD; PEDIOCIN PA 1; PEPTIDOGLYCAN; PERMEASE; PHEROMONE; PHOSPHOETHANOLAMINE; PHOSPHOLIPASE A2; PHOSPHOTRANSFERASE; PLANTARICIN A; PLANTARICIN EF; PLANTARICIN JK; POLYPEPTIDE ANTIBIOTIC AGENT; UNCLASSIFIED DRUG; UNINDEXED DRUG; ANTIINFECTIVE AGENT; DRUG DERIVATIVE; MURAMYL NAC (PENTAPEPTIDE)PYROPHOSPHORYL UNDECAPRENOL; MURAMYL-NAC-(PENTAPEPTIDE)PYROPHOSPHORYL-UNDECAPRENOL; PEPTIDE; PHOSPHATIDYLETHANOLAMINE; URIDINE DIPHOSPHATE N ACETYLMURAMIC ACID;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; BACTERIAL CELL WALL; BACTERIAL MEMBRANE; BACTERICIDAL ACTIVITY; CARBOHYDRATE SYNTHESIS; CELL FUNCTION; CELL MEMBRANE PERMEABILITY; CELL STRUCTURE; CHANNEL GATING; COMPLEX FORMATION; DRUG CLASSIFICATION; DRUG MECHANISM; DRUG PROTEIN BINDING; DRUG STRUCTURE; DRUG TARGETING; ENZYME INHIBITION; GRAM POSITIVE BACTERIUM; MEMBRANE BINDING; MEMBRANE DAMAGE; MEMBRANE MODEL; METABOLIC INHIBITION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PROTEIN MODIFICATION; PROTON MOTIVE FORCE; REVIEW; STAPHYLOCOCCUS INFECTION; STRUCTURE ACTIVITY RELATION; TARGET CELL; AMINO ACID SEQUENCE; BIOSYNTHESIS; METABOLISM; MOLECULAR GENETICS; PROTEIN PROCESSING;

BACTERIA (MICROORGANISMS); POSIBACTERIA;

AMINO ACID SEQUENCE; ANTI-BACTERIAL AGENTS; BACTERIOCINS; GRAM-POSITIVE BACTERIA; MOLECULAR SEQUENCE DATA; NISIN; PEPTIDES; PEPTIDOGLYCAN; PHOSPHATIDYLETHANOLAMINES; PROTEIN PROCESSING, POST-TRANSLATIONAL; URIDINE DIPHOSPHATE N-ACETYLMURAMIC ACID;

EID: 0036589242     PISSN: 03009084     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-9084(02)01417-7     Document Type: Review

References (87)

1. I.F. Nes, D.B. Diep, L.S. Havarstein, M.B. Brurberg, V. Eijsink, H. Holo, Biosynthesis of bacteriocins in lactic acid bacteria, Antonie Van Leeuwenhoek 70 (1996) 113-128.
2. T.R. Klaenhammer, Genetics of bacteriocins produced by lactic acid bacteria, FEMS Microbiol. Rev. 12 (1993) 39-85.
3. H.G. Sahl, R.W. Jack, J. Bierbaum, Biosynthesis and biological activities of lantibiotics with unique post-translational modifications, Eur. J. Biochem. 230 (1995) 827-853.
4. H.G. Sahl, G. Bierbaum, Lantibiotics - Biosynthesis and biological activities of uniquely modified peptides from Gram-positive bacteria, Annu. Rev. Microbiol. 52 (1998) 41-47.
5. A. Guder, I. Wiedemann, H.G. Sahl, Posttranslationally modified bacteriocins-the lantibiotics, Biopolymers 55 (2000) 62-73.
6. G. Jung, Lantibiotics-ribosomally synthesized biologically active polypeptides containing sulfide bridges and didehydroamino acids, Angewandte Chemie, Int. Ed. Engl. 30 (1991) 1051-1068.
7. R.W. Jack, G. Bierbaum, H.-G. Sahl, Lantibiotics and related peptides, Springer-Verlag, Berlin, Heidelberg, New York, 1998.
8. E. Gross, J.L. Morell, The structure of nisin, J. Am. Chem. Soc. 93 (1971) 4634-4635.
9. W. Liu, J.N. Hansen, The antimicrobial effect of a structural variant of subtilin against outgrowing Bacillus cereus T spores and vegetative cells occurs by different mechanisms, Appl. Environ. Microbiol. 59 (1993) 648-651.
10. H.R. Ramseier, Die Wirkung von Nisin auf Clostridium butyricum, Arch. Mikrobiol. 37 (1960) 57-94.
11. P.E. Linnett, J.L. Strominger, Additional antibiotic inhibitors of peptidoglycan synthesis, Antimicrob. Agents Chemother. 4 (1973) 231-236.
12. P. Reisinger, H. Seidel, H. Tschesche, P. Hammes, The effect of nisin on murein synthesis, Arch. Microbiol. 127 (1980) 187-193.
13. E. Ruhr, H.G. Sahl, Mode of action of the peptide antibiotic nisin: influence on the membrane potential of bacterial cells and on cytoplasmic and artificial membrane vesicles, Antimicrob. Agents Chemother. 27 (1985) 841-845.
14. H.G. Sahl, M. Kordel, R. Benz, Voltage-dependent depolarization of bacterial membranes and artificial lipid bilayers by the peptide antibiotic nisin, Arch. Microbiol. 149 (1987) 120-124.
15. H.G. Sahl, H. Brandis, Mode of action of the staphylococcin-like peptide Pep5 and culture conditions effecting its activity, Zbl. Bakt. Hyg. 252 (1982) 166-175.
16. H. Brötz, M. Josten, I. Wiedemann, U. Schneider, F. Götz, G. Bierbaum, et al., Role of lipid-bound peptidoglycan precursors in the formation of pores by nisin, epidermin and other lantibiotics, Mol. Microbiol. 30 (1998) 317-327.
17. E. Breukink, I. Wiedemann, C. van Kraaij, O.P. Kuipers, H.G. Sahl, B. de Kruijff, Use of the cell wall precursor lipid II by a pore-forming peptide antibiotic, Science 286 (1999) 2361-2364.
18. I. Wiedemann, E. Breukink, C. van Kraaij, O.P. Kuipers, G. Bierbaum, B. de Kruijff, et al., Specific binding of nisin to the peptidglycan precursor lipid II combines pore formation and inhibition of cell wall biosynthesis for potent antibiotic activity, J. Biol. Chem. 276 (2001) 1772-1779.
19. G.N. Moll, G.C.K. Roberts, W.N. Konings, A.J.M. Driessen, Mechanism of lantibiotic-induced pore formation, Antonie van Leeuwenhoek 69 (1996) 185-191.
20. G. Bierbaum, H.G. Sahl, Induction of autolysis of staphylococci by the basic peptide antibiotic Pep5 and nisin and their influence on the activity of autolytic enzymes, Arch. Microbiol. 141 (1985) 249-254.
21. G. Bierbaum, H.G. Sahl, Autolytic system of Staphylococcus simulans 22: influence of cationic peptides on activity of N-acetylmuramoyl-L-alanine amidase, J. Bacteriol. 169 (1987) 5452-5458.
22. Z. Oren, Y. Shai, Mode of action of linear amphiphatic, alpha-helical antimicrobial peptides, Biopolymers 47 (1998) 451-463.
23. R. Benz, G. Jung, H.G. Sahl, Mechanism of channel-formation by lantibiotics in black lipid membranes, in: G. Jung, H.-G. Sahl (Eds.), Nisin and Novel Lantibiotics, Escom, Leiden, 1991, pp. 359-372.
24. G. Boheim, Statistical analysis of alamethicin channels in black lipid membranes, J. Membr. Biol. 19 (1974) 277-303.
25. V. Rizzo, S. Stankowski, G. Schwarz, Alamethicin incorporation in lipid bilayers: a thermodynamic study, Biochemistry 19 (1987) 2751-2759.
26. H.W. van den Hooven, C.C.M. Doeland, M. van de Kamp, R.N.H. Konings, C.W. Hilbers, F.J.M. van de Ven, Three-dimensional structure of the lantibiotic nisin in the presence of membrane-mimetic micelles of dodecylphosphocholine and of sodium dodecylsulphate, Eur. J. Biochem. 235 (1996) 382-393.
27. H.W. van den Hooven, C.A.E.M. Spronk, M. van de Kamp, R.N.H. Konings, C.W. Hilbers, F.J.M. van de Ven, Surface location and orientation of the lantibiotic nisin bound to membrane-mimicking micelles of dodecylphophocholine and of sodium dodecylsulphate, Eur. J. Biochem. 235 (1996) 394-403.
28. A.J.M. Driessen, H.W. van den Hooven, W. Kuiper, M. van de Kamp, H.G. Sahl, R.N.H. Konings, et al., Mechanistic studies of lantibiotic-induced permeabilization of phospholipid vesicles, Biochemistry 34 (1995) 1606-1614.
29. L.Y. Lian, W.C. Chan, S.D. Morley, G.C.K. Roberts, B.W. Bycroft, D. Jackson, Solution structures of nisin and its two major degradation products determined by NMR, Biochem. J. 283 (1991) 413-420.
30. F.J.M. van de Ven, H. W. van den Hooven, R.N.H. Konings, C.W. Hilbers, The spatial structure of nisin in aqueous solution, in: G. Jung, H.-G. Sahl (Eds.), Nisin and Novel Lantibiotics, Escom, Leiden, 1991, pp. 35-42.
31. R.A. Demel, T. Peelen, R.J. Siezen, B. de Kruijff, O.P. Kuipers, Z Nisin, mutant nisin Z and lacticin 481 interactions with anionic lipids correlate with antimicrobial activity - a monolayer study, Eur. J. Biochem. 235 (1996) 267-274.
32. E. Breukink, C. van Kraaij, R.A. Demel, R.J. Siezen, O.P. Kuipers, B. de Kruijff, The C-terminal region of nisin is responsible for the initial interaction of nisin with the target membrane, Biochemistry 36 (1997) 6968-6976.
33. C. vanKraaij, E. Breukink, M.A. Noordermeer, R.A. Demel, R.J. Siezen, O.P. Kuipers, et al., Pore formation by nisin involves translocation of its C-terminal part across the membranes, Biochemistry 37 (1998) 16033-16040.
34. C.J. Giffard, S. Ladha, A.R. Mackie, D.C. Clark, D. Sanders, Interaction of nisin with planar lipid bilayers monitored by fluorescence recovery after photobleaching. J. Membr. Biol. 151 (1996) 293-300.
35. K. Winkowski, R.D. Ludescher, T.J. Montville, Physicochemical characterization of the nisin-membrane interaction with liposomes derived from Listeria monocytogenes, Appl. Environ. Microbiol. 62 (1996) 323-327.
36. W.C. Chan, M.L. Leyland, J. Clark, H.M. Dodd, L.Y. Lian, M.J. Gasson, et al., Structure-activity relationships in the peptide antibiotic nisin: antibacterial activity of fragments of nisin, FEBS Lett. 390 (1996) 129-132.
37. V. Arioli, M. Berti, L.G. Silvestri, Gardimycin, a new antibiotic from Actinoplanes, III. Biological properties, J. Antibiot. 29 (1976) 511-515.
38. M. Limbert, D. Isert, N. Klesel, A. Markus, G. Seibert, S. Chatterjee, et al., Chemotherapeutic properties of mersacidin in vitro and in vivo, in: G. Jung, H.-G. Sahl (Eds.), Nisin and Novel Lantibiotics, Escom, Leiden, 1991, pp. 448-456.
39. W.W. Niu, H.C. Neu, Activity of mersacidin, a novel peptide, compared with that of vancomycin, teicoplanin, and daptomycin, Antimicrob. Agents Chemother. 35 (1991) 998-1000.
40. H. Brötz, G. Bierbaum, P.E. Reynolds, H.G. Sahl, The lantibiotic mersacidin inhibits peptidoglycan biosynthesis at the level of transglycosylation, Eur. J. Biochem. 246 (1997) 193-199.
41. H. Brötz, G. Bierbaum, K. Leopold, P.E. Reynolds, H.G. Sahl, The lantibiotic mersacidin inhibits peptidoglycan synthesis by targeting lipid II, Antimicrob. Agents Chemother. 42 (1998) 154-160.
42. N. Zimmermann, J.W. Metzger, G. Jung, The tetracycline lantibiotic actagardine: 1H-NMR and 13C-NMR assignments and revised primary structure, Eur. J. Biochem. 228 (1995) 786-797.
43. E. Racker, C. Riegler, M. Abdel-Ghany, Stimulation of glycolysis by placental polypeptides and inhibition by duramycin, Cancer 44 (1983) 1364-1367.
44. L.L. Chen, P.C. Tai, Effects of antibiotics and other inhibitors on ATP-dependent protein translocation into membrane vesicles, J. Bacteriol. 169 (1987) 2372-2379.
45. J. Navarro, J. Chabot, K. Sherril, R. Aneja, S.A. Zahler, Interaction of duramycin with artificial and natural membranes, Biochemistry 24 (1985) 4645-4650.
46. A. Fredenhagen, F. Märki, G. Fendrich, W. Märki, J. Gruner, J. van Oostrum, et al., Duramycin B and C, two new lanthionine-containing antibiotics as inhibitors of phospholipase A2, and structural revision of duramycin and cinnamycin, in: G. Jung, H.-G. Sahl (Eds.), Nisin and Novel Lantibiotics, Escom, Leiden, 1991, pp. 131-140.
47. K. Hosoda, M. Ohya, T. Kohno, T. Maeda, S. Endo, W. Wakamatsu, Structure determination of an immunopotentiator peptide, cinnamycin, complexed with lysophophatidylethanolamine by 1H-NMR, J. Biochem. 119 (1996) 226-230.
48. S.Y. Choung, T. Kobayashi, J. Inoue, Haemolytic activity of a cyclic peptide Ro, Biochim. Biophys. Acta 940 (1988) 171-179.
49. F. Märki, E. Hänni, A. Fredenhagen, J. van Oostrum, Mode of action of the lanthionine-containing peptide antibiotics duramycin, duramycin B and C, and cinnamycin as indirect inhibitors of phospholipase A2, Biochem. Pharmacol. 42 (1991) 2027-2031.
50. I.F. Nes, H. Holo, Class II antimicrobial peptides from lactic acid bacteria, Biopolymers 55 (2000) 50-61.
51. S. Ennahar, T. Sashihara, K. Sonomoto, A. Ishizaki, Class IIa bacteriocins: biosynthesis, structure and activity, FEMS Microbiol. Rev. 24 (2000) 85-106.
52. A.K. Bhunia, M.C. Johnson, B. Ray, N. Kalchayanand, Mode of action of pediocin AcH from Pediococcus acidilactici H on sensitive bacterial strains, J. Appl. Bacteriol. 70 (1991) 25-33.
53. M.L. Chikindas, M.J. Garcia-Garcera, A.J. Driessen, A.M. Ledeboer, J. Nissen-Meyer, I.F. Nes, et al., Pediocin PA-1, a bacteriocin from Pediococcus acidilactici PAC1.0, forms hydrophilic pores in the cytoplasmic membrane of target cells, Appl. Environ. Microbiol. 59 (1993) 3577-3584.
54. Y. Chen, R. Shapira, M. Eisenstein, T.J. Montville, Functional characterization of pediocin PA-1 binding to liposomes in the absence of a protein-receptor and its relationship to a predicted tertiary structure, Appl. Environ. Microbiol. 63 (1997) 524-531.
55. Y. Chen, R.D. Ludescher, T.J. Montville, Influence of lipid composition on pediocin PA-1 binding to phospholipid vesicles, Appl. Environ. Microbiol. 64 (1998) 3530-3532.
56. Y. Chen, R.D. Ludescher, T.J. Montville, Electrostatic interactions, but not the YGNGV consensus motif, govern the binding of pediocin PA-1 and its fragments to phospholipid vesicles, Appl. Environ. Microbiol. 63 (1997) 4770-4777.
57. G. Fimland, R. Jack, G. Jung, I.F. Nes, I. Nissen-Meyer, The bactericidal activity of pediocin PA-1 is specifically inhibited by a 15-mer fragment that spans the bacteriocin from the center toward the C terminus, Appl. Environ. Microbiol. 64 (1998) 5057-5060.
58. D.P. Christensen, R.W. Hutkins, Collapse of the proton motive force in Listeria monocytogenes caused by a bacteriocin produced by Pediococcus acidilactici, Appl. Environ. Microbiol. 58 (1992) 3312-3315.
59. B.L. Waite, R.W. Hutkins, Bacteriocins inhibit glucose PEP:PTS activity in Listeria monocytogenes by induced efflux of intracellular metabolites, J. Appl. Microbiol. 85 (1998) 287-292.
60. B.L. Waite, G.R. Siragusa, R.W. Hutkins, Bacteriocin inhibition of two glucose transport systems in Listeria monocytogenes, J. Appl. Microbiol. 84 (1998) 715-721.
61. A.L. Kaiser, T.J. Montville, Purification of the bacteriocin bavaricin MN and characterization of its mode of action against Listeria monocytogenes Scott A cells and lipid vesicles, Appl. Environ. Microbiol. 62 (1996) 4529-4535.
62. P. Bhugaloo-Vial, J.P. Douliez, D. Moll, X. Dousset, P. Boyaval, D. Marion, Delineation of key amino acid side chains and peptide domains for antimicrobial properties of divercin V41, a pediocin-like bacteriocin secreted by Carnobacterium divergens V41, Appl. Environ. Microbiol. 65 (1999) 2895-2900.
63. N.L. Fregeau Gallagher, M. Sailer, W.P. Niemczura, T.T. Nakashima, M.E. Stiles, J.C. Vederas, Three-dimensional structure of leucocin A in trifluoroethanol and dodecylphosphocholine micelles: spatial location of residues critical for biological activity in type IIa bacteriocins from lactic acid bacteria, Biochemistry 36 (1997) 15062-15072.
64. Y. Hechard, C. Jayat, F. Letellier, R. Jullen, Y. Cenatiempo, M.H. Ratinaud, On-line visualization of the competitive behavior of antagonistic bacteria. Appl. Environ. Microbiol. 58 (1992) 3784-3786.
65. A. Maftah, D. Renault, C. Vignoles, Y. Hechard, P. Bressollier, M.H. Ratinaud, et al., Membrane permeabilization of Listeria monocytogenes and mitochondria by the bacteriocin mesentericin Y105, J. Bacteriol. 175 (1993) 3232-3235.
66. Y. Fleury, M.A. Dayem, J.J. Montagne, E. Chaboisseau, J.P. Le Caer, P. Nicolas, et al., Covalent structure, synthesis, and structure-function studies of mesentericin Y 105(37), a defensive peptide from Gram-positive bacteria Leuconostoc mesenteroides, J. Biol. Chem. 271 (1996) 14421-14429.
67. D. Robichon, E. Gouin, M. Débarbouillé, P. Cossart, Y. Cenatiempo, Y. Héchard, The rpoN (sigma54) gene from Listeria monocytogenes is involved in resistance to mesentericin Y105, an antibacterial peptide from Leuconostoc mesenteroides, J. Bacteriol. 1979 (1997) 7591-7594.
68. K. Dalet, C. Briand, Y. Cenatiempo, Y. Hechard The rpoN gene of Enterococcus faecalis directs sensitivity to subclass IIa bacteriocins, Curr. Microbiol. 41 (2000) 441-443.
69. K. Dalet, Y. Cenatiempo, P. Cossart, Y. Hechard, A sigma(54)-dependent PTS permease of the mannose family is responsible for sensitivity of Listeria monocytogenes to mesentericin Y105, Microbiology 147 (2001) 3263-3269.
70. Y. Hechard, C. Pelletier, Y. Cenatiempo, J. Frere, Analysis of sigma(54)-dependent genes in Enterococcus faecalis: a mannose PTS permease (EII(Man) is involved in sensitivity to a bacteriocin, mesentericin Y105, Microbiology 147 (2001) 1575-1580.
71. M. Ramnath, M. Beukes, K. Tamura, J.W. Hastings, Absence of a putative mannose-specific phosphotransferase system enzyme IIAB component in leucocin A-resistant strain of Listeria monocytogenes, as shown by two-dimensional sodium dodecyl sulfate-polyacrylamide gel electrophoresis, Appl. Environ. Microbiol. 66 (2000) 3098-3101.
72. L.Z. Yan, A.C. Gibbs, M.E. Stiles, D.S. Wishart, J.C. Vederas, Analogues of bacteriocins: antimicrobial specificity and interactions of leucocin A with its enantiomer, carnobacteriocin B2, and truncated derivatives, J. Med. Chem. 43 (2000) 4579-4581.
73. L.M. Cintas, P. Casaus, L.S. Havarstein, P.E. Hernandez, I.F. Nes, Biochemical and genetic characterization of enterocin P, a novel sec-dependent bacteriocin from Enterococcus faecium P13 with a broad antimicrobial spectrum, Appl. Environ. Microbiol. 63 (1997) 4321-4330.
74. C. Herranz, L.M. Cintas, P.E. Hernandez, G.N. Moll, A.J. Driessen, Enterocin P causes potassium ion eflux from Enterococcus faecium T136 cells, Antimicrob. Agents Chemother. 45 (2001) 901-904.
75. C. Herranz, Y. Chen, H.J. Chung, L.M. Cintas, P.E. Hernandez, T.J. Montville, et al., Enterocin P selectively dissipates the membrane potential of Enterococcus fecium T136, Appl. Environ. Microbiol. 67 (2001) 1689-1692.
76. T. Abee, T.R. Klaenhammer, L. Letellier, Kinetic studies of the action of lactacin F, a bacteriocin produced by Lactobacillus johnsonii that forms poration complexes in the cytoplasmic membrane, Appl. Environ. Microbiol. 60 (1994) 1006-1013.
77. G.N. Moll, E. van den Akker, H.H. Hauge, J. Nissen-Meyer, I.F. Nes, W.N. Konings, et al., Complementary and overlapping selectivity of the two-peptide bacteriocins plantaricin EF and JK, J. Bacteriol. 181 (1999) 4848-4852.
78. J. Nissen-Meyer, H. Holo, L.S. Havarstein, K. Sletten, I.F. Nes, A novel lactococcal bacteriocin whose activity depends on the complementary action of two peptides, J. Bacteriol. 174 (1992) 5686-5692.
79. G. Moll, T. Ubbink-Kok, H. Hildeng-Hauge, J. Nissen-Meyer, I.F. Nes, W.N. Konings, et al., Lactococcin G is a potassium ion-conducting, two-component bacteriocin, J. Bacteriol. 178 (1996) 600-605.
80. G. Moll, H. Hildeng-Hauge, J. Nissen-Meyer, I.F. Nes, W.N. Konings, A.J. Driessen, Mechanistic properties of the two-component bacteriocin lactococcin G, J. Bacteriol. 180 (1998) 96-99.
81. H.H. Hauge, D. Mantzilas, G.N. Moll, W.N. Konings, A.J. Driessen, V.G. Eijsink, et al., Plantaricin A is an amphiphilic alpha-helical bacteriocin-like pheromone which exerts antimicrobial and pheromone activities through different mechanisms, Biochemistry 37 (1998) 16026-16032.
82. M.J. Van Belkum, J. Kok, G. Venema, H. Holo, I.F. Nes, W.N. Konings, et al., The bacteriocin lactococcin A specifically increases permeability of lactococcal cytoplasmic membranes in a voltage-independent, protein-mediated manner, J. Bacteriol. 173 (1991) 7934-7941.
83. B. Martinez, J.E. Suarez, A. Rodriguez, Lactococcin 972: a homodimeric lactococcal bacteriocin whose primary target is not the plasma membrane, Microbiology 142 (1996) 2393-2398.
84. B. Martinez, M. Fernandez, J.E. Suarez, A. Rodriguez, Synthesis of lactococcin 972, a bacteriocin produced by Lactococcus lactis IPLA 972, depends on the expression of a plasmid-encoded bicistronic operon, Microbiology 145 (1999) 3155-3161.
85. B. Martinez, A. Rodriguez, J.E. Suarez, Lactococcin 972, a bacteriocin that inhibits septum formation in lactococci, Microbiology 146 (2000) 949-955.
86. G.N. Moll, W.N. Konings, A.J. Driessen, Bacteriocins: mechanism of membrane insertion and pore formation, Antonie Van Leeuwenhoek 76 (1999) 185-198.
87. M. Rasch, S. Knochel, Variations in tolerance of Listeria monocytogenes to nisin, pediocin PA-1 and bavaricin A, Lett. Appl. Microbiol. 27 (1998) 275-278.